Long-term Clinical Outcomes of Patients with Sympathetic Ophthalmia

Overview

Journal Int Ophthalmol

Specialty Ophthalmology

Date 2024 Feb 7

PMID 38324101

Authors

Neofytos Mavris

Radgonde Amer

Affiliations

Soon will be listed here.

Abstract

Purpose: To present the long-term clinical outcomes of patients with sympathetic ophthalmia (SO).

Methods: Retrospective review of patients' medical files between 2002 and 2022.

Results: Included were seven patients (four males). The mean ± SD age at presentation was 37.9 ± 22.5 years. Four patients had co-morbidities: three had diabetes mellitus type 2 and one had Turner Syndrome. Trauma was the inciting event in six patients and postoperative endophthalmitis in one patient. Decreased visual acuity (VA) was the leading symptom in the sympathizing eye and all of the patients presented with panuveitis. The mean ± SD interval between the triggering incident and the onset of SO in six cases was 4.3 ± 4.2 months. One case presented 30 years following the eye injury. Five patients underwent enucleation/evisceration of the exciting eye. The mean ± SD presenting LogMAR BCVA in the sympathizing eye was 0.57 ± 0.82, and the final LogMAR BCVA was 0.61 ± 0.95. Inflammation was completely controlled in 5 patients at a mean ± SD of 8.55 ± 9.21 months following the institution of immunomodulatory therapy, and it was partially controlled in 2 patients. VA deteriorated in all 3 diabetic patients and improved or remained stable in the 4 young and healthy patients. The mean ± SD follow-up period after achieving drug-free remission was 28 ± 22.8 months. The mean ± SD follow-up time was 6.8 ± 5.6 years.

Conclusions: SO is one of the most sight-threatening conditions, affecting the healthy eye. In this cohort, the favorable visual outcome was especially seen in young and healthy individuals. Visual prognosis is directly related to prompt diagnosis and treatment.

References

Savar A, Andreoli M, Kloek C, Andreoli C . Enucleation for open globe injury. Am J Ophthalmol. 2009; 147(4):595-600.e1. DOI: 10.1016/j.ajo.2008.10.017. View

Jabs D, Nussenblatt R, Rosenbaum J . Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140(3):509-16. PMC: 8935739. DOI: 10.1016/j.ajo.2005.03.057. View

Yang J, Li Y, Xie R, Li X, Zhang X . Sympathetic ophthalmia: Report of a case series and comprehensive review of the literature. Eur J Ophthalmol. 2020; 31(6):3099-3109. DOI: 10.1177/1120672120977359. View

Chu X, Chan C . Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthalmic Inflamm Infect. 2013; 3(1):49. PMC: 3679835. DOI: 10.1186/1869-5760-3-49. View

Gupta V, Gupta A, Dogra M . Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India. Eye (Lond). 2007; 22(12):1459-64. DOI: 10.1038/sj.eye.6702927. View

Chan C, Roberge R, Whitcup S, Nussenblatt R . 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Arch Ophthalmol. 1995; 113(5):597-600. DOI: 10.1001/archopht.1995.01100050065032. View

Williams A, Shepler A, Chu C, Nischal K . Sympathetic ophthalmia presenting 5 days after penetrating injury. Am J Ophthalmol Case Rep. 2020; 19:100816. PMC: 7363657. DOI: 10.1016/j.ajoc.2020.100816. View

Lubin J, Albert D, Weinstein M . Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology. 1980; 87(2):109-21. DOI: 10.1016/s0161-6420(80)35270-6. View

Albert D . A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol. 1989; 34(1):1-14. DOI: 10.1016/0039-6257(89)90125-2. View

10.

Gomes Pereira J, Vaz-de-Macedo C, Almeida M, Canelas L . Endometriosis-Related Spontaneous Hemoperitoneum in the Third Trimester: A Case Report. Cureus. 2023; 14(12):e32897. PMC: 9869646. DOI: 10.7759/cureus.32897. View

10.

Zaharia M, Lamarche J, Laurin M . Sympathetic uveitis 66 years after injury. Can J Ophthalmol. 1984; 19(5):240-3. View

11.

Almeida C, Venade G, Duarte D, Vaz A, Nascimento E . Type 1 Diabetes Mellitus and Multiple Sclerosis: An Association to Consider. Cureus. 2022; 14(10):e30762. PMC: 9701081. DOI: 10.7759/cureus.30762. View

11.

Ahmed S, Deshpande S, Chhatbar K . Osteosarcoma of the Distal Femur Presenting as Giant Cell Tumor: A Case Report. Cureus. 2023; 14(12):e33173. PMC: 9886414. DOI: 10.7759/cureus.33173. View

12.

Lee J, Choe Y, Jeong H, Kim M, Kim S, Yoo H . Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021. J Korean Med Sci. 2021; 36(50):e346. PMC: 8728587. DOI: 10.3346/jkms.2021.36.e346. View

12.

Ahmed K, Siddiqui M, Sarwar H . Imaging of Classic Dalén Fuchs Nodules in Sympathetic Ophthalmia With Spectral Domain OCT. Cureus. 2022; 14(1):e20876. PMC: 8803370. DOI: 10.7759/cureus.20876. View

13.

Lara L, Ocampo Jr V . Prevalence of presumed ocular tuberculosis among pulmonary tuberculosis patients in a tertiary hospital in the Philippines. J Ophthalmic Inflamm Infect. 2013; 3(1):1. PMC: 3589205. DOI: 10.1186/1869-5760-3-1. View

13.

Park J, Yang S, Choi H . Epidemiology and Clinical Patterns of Ocular Trauma at a Level 1 Trauma Center in Korea. J Korean Med Sci. 2021; 36(1):e5. PMC: 7781856. DOI: 10.3346/jkms.2021.36.e5. View

14.

Reynard M, RIFFENBURGH R, Minckler D . Morphological variation of Dalén-Fuchs nodules in sympathetic ophthalmia. Br J Ophthalmol. 1985; 69(3):197-201. PMC: 1040562. DOI: 10.1136/bjo.69.3.197. View

15.

MAKLEY Jr T, Azar A . Sympathetic ophthalmia. A long-term follow-up. Arch Ophthalmol. 1978; 96(2):257-62. DOI: 10.1001/archopht.1978.03910050125004. View

16.

He B, Tanya S, Wang C, Kezouh A, Torun N, Ing E . The Incidence of Sympathetic Ophthalmia After Trauma: A Meta-analysis. Am J Ophthalmol. 2021; 234:117-125. DOI: 10.1016/j.ajo.2021.06.036. View